TRV GP VI, LLC

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$243.9M2026 Q3
Positions5
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

TRV GP VI, LLC reported 5 positions worth $243.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: SEPN (67.6%). Biggest move: new buy LSTA ($69.8K).

5 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SEPNSepterna$164.8M67.58%4,211,659——+8.9%
▸ 2 SPTXSeaport Therapeutics$41.6M17.05%2,061,222——-0.9%
▸ 3 RAPPRapport Therapeutics$32.6M13.35%969,218——-22.2%
▸ 4 TNGXTango Therapeutics$4.8M1.99%194,174——+2.2%
▸ 5 LSTALisata Therapeutics$69.8K0.03%48,446———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does TRV GP VI, LLC hold as of Q3 2026?

TRV GP VI, LLC reported 5 positions worth $243.9M in its Q3 2026 13F filing. Largest positions: SEPN (67.6%), SPTX (17.0%), RAPP (13.4%), TNGX (2.0%) and LSTA (0.0%).

What did TRV GP VI, LLC buy in Q3 2026?

New positions: LSTA.

What did TRV GP VI, LLC sell in Q3 2026?

TRV GP VI, LLC reduced or sold out of no positions in Q3 2026.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.